Abstract
To the Editor: The 34th most commonly prescribed medication in the United States in 1983 was an eye drop used in the management of glaucoma, timolol (Timoptic, Merck Sharp and Dohme). Beta-blocking agents given for the topical ophthalmic effects are contraindicated in patients with bronchial asthma, bronchospasm, or severe chronic obstructive pulmonary disease. The National Registry of Drug-Induced Ocular Side Effects, at the Department of Ophthalmology, Oregon Health Sciences University, has now received over 200 reports of possible major timolol-induced respiratory effects. Although the manufacturer's package insert has included asthma as a contraindication to timolol administration since 1983, physicians and.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1441 |
| Number of pages | 1 |
| Journal | New England Journal of Medicine |
| Volume | 311 |
| Issue number | 22 |
| DOIs | |
| State | Published - Nov 29 1984 |
ASJC Scopus subject areas
- General Medicine
Fingerprint
Dive into the research topics of 'Respiratory Effects of Timolol'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS